Table 2.

General characteristics after PSM.

	Normal weight (n = 1,155)	Overweight (n = 1,155)	p*
Age, mean(SD)	59.63(10.59)	59.7(10.32)	0.870
Gender, n(%)			0.881
Female	256	260
Male	899	895
Smoke, n(%)			0.900
No	655	659
Yes	500	496
HTN, n(%)			0.521
No	703	719
Yes	452	436
DM, n(%)			0.885
No	866	870
Yes	289	285
HCC cause, n(%)			0.996
HBV	733	737
HCV	130	132
NBNC	20	22
Alcohol	125	118
Mixed (HBV + HCV)	10	11
Unknown	137	135
Laboratory findings ALT, mean(SD)	45.6(1.95)	49.38(2.08)	0.644
Albumin, mean(SD)	3.96(0.57)	3.95(0.56)	0.659
Platelet, mean(SD)	142.61(68.01)	141.39(69.14)	0.667
PT(INR), mean(SD)	1.11(0.14)	1.11(0.15)	0.318
Cr, mean(SD)	0.93(0.59)	0.92(0.42)	0.652
Na, mean(SD)	139.72(3.62)	139.73(3.07)	0.890
Total cholesterol, mean(SD	160.22(37.98)	160.73(37.02)	0.745
AFP, mean(SD)	1162.94(5992.19)	1132.1(7435.5)	0.913
CTP class, n(%)			0.639
1	1034	1026
2	121	129
MELD score, mean(SD)	8.61(2.51)	8.65(2.5)	0.648
MELD-Na, mean(SD)	9.54(3.16)	9.6(3.16)	0.626
Tumor number, n(%)			0.918
Single	812	814
Multiple	343	341
Tumor size, mean(SD)	288.8 (43.0)	288.8 (37.3)	0.911
BCLC stage, n(%)			0.968
0	163	160
A	776	775
B	216	220

*p values were calculated using the t-test or Fisher’s exact test.

PSM, propensity score matching; SD, standard deviation; HTN, hypertension; DM, diabetes mellitus; HCC, hepatocellular carcinoma; HBV, hepatitis B virus; HCV, hepatitis C virus; NBNC, non-hepatitis B and non-hepatitis C; ALT, aminotransferase; PT, prothrombin time; INR, international normalized ratio; Cr, creatinine; Na, sodium; AFP, alpha-fetoprotein; CTP, Child-Turcotte-Pugh; MELD, model for end-stage liver disease; BCLC, Barcelona Clinic Liver Cancer.